Publisher
Springer International Publishing
Reference11 articles.
1. Hulley S, Grady D, Bush T. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280(7):605–13. https://doi.org/10.1001/jama.280.7.605.
2. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–12. https://doi.org/10.1001/jama.291.14.1701.
3. Mosca L, Collins P, Herrington DM, Mendelsohn ME, Pasternak RC, Robertson RM, et al. Hormone replacement therapy and cardiovascular disease. Circulation. 2001;104:499–503.
4. Gartlehner G, Patel S, Viswanathan M, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: an evidence review for the US preventive services task force: evidence synthesis no. 155. Rockville, MD: Agency for Healthcare Research and Quality. AHRQ Publication; 2017. 15-05227-EF-1.
5. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243–62. https://doi.org/10.1161/CIR.0b013e31820faaf8.